Reply to “Letter to the editor of Annals of Surgical Oncology Concerning “ The Landmark Series: Multimodality Therapy for Stage 3A Non-small Cell Lung Cancer” by Sunil Kumar et al.
Crossref DOI link: https://doi.org/10.1245/s10434-020-09258-z
Published Online: 2020-10-26
Published Print: 2021-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Eby, Marcus
Seder, Christopher W.
Text and Data Mining valid from 2020-10-26
Version of Record valid from 2020-10-26
Article History
Received: 28 September 2020
Accepted: 4 October 2020
First Online: 26 October 2020